12 August 2008 - IMGM Laboratories GmbH has achieved Certified Service Provider status for the Agilent microarray platform
SANTA CLARA, Calif., and MARTINSRIED, Germany, 12 August 2008: Agilent Technologies Inc. (NYSE: A) today announced that IMGM Laboratories GmbH has achieved Certified Service Provider status for the Agilent microarray platform.
IMGM achieved Agilent-certified status after completing training and passing a rigorous series of assessments that include: demonstrating proficiency in analyzing Agilent’s 60-mer oligo microarrays using the complete Agilent system; sample quality control using the Agilent 2100 Bioanalyzer; sample labeling using Agilent reagents and protocols; hybridization using SureHyb chambers; microarray analysis using the Agilent scanner and feature extraction software; and final data analysis using the GeneSpring bioinformatics platform.
“By switching to this powerful microarray platform, we’re able to further increase the value of our whole-genome gene expression service,” said Ralph Oehlmann, director of business development at IMGM. “In addition to offering our customers new applications, our service brings together high data quality, sound bioinformatics and clear, detailed reports.”
“I am very pleased to welcome IMGM as a Certified Service Provider,” said Chris Grimley, Agilent senior marketing director, Genomics. “They’ve demonstrated a quality approach to supporting customers’ research, and we look forward to a long and productive relationship.”
For more information about IMGM, please visit www.imgm.com. For more information about Agilent’s Genomics portfolio, please visit www.opengenomics.com.
About IMGM Laboratories GmbH
IMGM Laboratories, founded in 2001, is located at the biotech-campus Martinsried, near Munich, Germany. IMGM is one of Europe’s leading genomic service providers, offering advanced genomic services tailored to the needs of customers coming from academia, pharma and biotech. IMGM gained wide acceptance for its excellent microarray-based whole genome gene expression analyses combined with an expert bioinformatics service for complex data sets. IMGM is accredited according to DIN EN ISO/IEC 17025 and is fully accredited for gene expression analysis based on whole genome microarrays and quantitative real-time PCR. For more information on IMGM’s service portfolio, please visit www.imgm.com.
About Agilent in Genomics
Agilent is a leading worldwide provider of microarray-based, genomics research solutions. Agilent’s end-to-end solution includes reagents for sample preparation and microarray processing; hardware for sample QC and high-throughput microarray scanning; 60-mer oligo microarrays on industry-standard 1” x 3” glass slides for gene expression; comparative genomic hybridization, microRNA, splice variants and chromatin immunoprecipitation applications; custom microarray design services; and industry-leading GeneSpring software products for data analysis.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. The company’s 19,000 employees serve customers in more than 110 countries. Agilent had net revenues of $5.4 billion in fiscal 2007. Information about Agilent is available on the Web at www.agilent.com.
NOTE TO EDITORS: Further technology, corporate citizenship and executive news is available on the Agilent news site at www.agilent.com/go/news.
Press release URL: http://www.agilent.com/about/newsroom/presrel/2008/12aug-ca08065.html